Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

uniQure N.V. (QURE) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

uniQure N.V. (QURE), most recent 12 months reported: revenue $18.09M, net loss $208.87M, free cash flow -$172.56M. Latest balance sheet on file: liquid cash $586.55M. From SEC filings. Others in Pharmaceutical Preparations: Sol-Gel Technologies Ltd. · SCYNEXIS, Inc. · Celularity Inc. · CytomX Therapeutics, Inc. · EVOFEM BIOSCIENCES, INC. · Zhengye Biotechnology Holding Limited · EMMAUS LIFE SCIENCES, INC. · Keros Therapeutics, Inc.

Stock screener

Watchlist